Involvement of erythrocyte skeletal proteins in the modulation of membrane fluidity by phenothiazines.
The effects of phenothiazines (chlorpromazine, chlorpromazine sulfoxide, and trifluoperazine) and antimitotic drugs (colchicine and vinblastine) on the erythrocyte membrane have been investigated. Chlorpromazine and trifluoperazine induced a dose-dependent increase in the freedom of motion of stearic acid spin-labels bound to both intact erythrocytes and ghosts, but did not affect the freedom of motion of stearic acids bound to vesicles depleted of spectrin and actin or of ghosts resealed with anti-spectrin antibodies. Further, chlorpromazine and trifluoperazine were able to eliminate a protein 4.1 dependent membrane thermal transition detected by stearic acid spin-labels at 8.5 +/- 1.5 degrees C. Antimitotic drugs and chlorpromazine sulfoxide did not change either the freedom of motion of stearic acid spin-labels or the 8.5 degrees C membrane thermal transition. Results indicate the involvement of skeletal proteins as possible membrane target sites of biologically active phenothiazines and suggest that the control of stearic acid spin-label freedom of motion is mediated by the spectrin-actin network and the proteins that link the skeletal network to the membrane.
Minetti
M
M
Laboratorio di Biologia Cellulare, Istituto Superiore di Sanitá, Roma, Italy.
Di Stasi
A M
AM
D002746:Chlorpromazine / Q000031:analogs & derivatives* / Q000494:pharmacology*; D003078:Colchicine / Q000494:pharmacology; D004578:Electron Spin Resonance Spectroscopy; D004910:Erythrocyte Membrane / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D008560:Membrane Fluidity / Q000187:drug effects*; D008565:Membrane Proteins / Q000097:blood*; D014268:Trifluoperazine / Q000494:pharmacology*; D014747:Vinblastine / Q000494:pharmacology
D008565:Membrane Proteins; C026714:opromazine; D014268:Trifluoperazine; D014747:Vinblastine; D003078:Colchicine; D002746:Chlorpromazine